NCT04085224

6x3 Crossover, Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volunteers

A Randomized, Open Label, Single Subcutaneous Dose 6x3 Crossover Study to Investigate the Relative Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: LG Chem · Industry
• Sex: All
• Age: 19 Years – 40 Years
• Healthy volunteers: Accepted

Summary

A Randomized, Open Label, Single Subcutaneous Dose 6x3 Crossover Study to Investigate the Relative Bioavailability, Safety and Tolerability among Different Eutropin Formulations in Healthy Volunteers

Conditions

• Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volunteers

Interventions

Type	Name	Description
DRUG	Somatropin	LG Somatropin

Timeline

• Start date: 2019-09-10
• Primary completion: 2020-01-02
• Completion: 2020-01-02
• First posted: 2019-09-11
• Last updated: 2020-03-24

Locations

1 site across 1 country: South Korea